Endocardial LV lead for resynchronization therapy - a viable alternative.
Authors:
Ryle Przybylowicz MD
Miranda Merrill MD
Nicholas J. Abbott MD
Angela Krebsbach PA
Peter M. Jessel MD
Bassel Beitinjaneh MD
Charles A. Henrikson MD
Oregon Health & Sciences University, Knight Cardiovascular Institute; Legacy Health System; Portland Veterans Affairs Medical Center
Funding: None
Disclosures:
Charles A. Henrikson, MD:
Fellowship support: Abbott, Boston Scientific, Medtronic
Data monitoring committee: Medtronic Clinical endpoints committee: Biotronik.